Events & Conferences

In this section, explore the key scientific events and conferences where Clinisciences takes center stage—whether as a sponsor or an active participant. From high-impact international congresses to focused expert symposia, our presence reflects our dedication to advancing research and connecting with the scientific community. These events are more than just dates on a calendar—they're opportunities to exchange ideas, showcase innovative tools, and stay at the forefront of scientific discovery. Join us where breakthroughs happen!

Webinar: Advancing drug screening and mechanism studies using TR-FRET

Modern drug discovery demands assay technologies that are fast, reliable, and scalable, yet conventional screening methods often suffer from labor-intensive workflows, high background interference, and limited throughput. In this webinar, we explore how Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) overcomes these limitations through its homogeneous mix-and-read format and superior signal-to-background ratio. Attendees will discover the core principles of TR-FRET and its powerful applications in high-throughput screening, functional assays, and mechanism-of-action studies, enabling simplified workflows, increased capacity, and greater confidence in experimental results.

Webinar: Preventing Sample Mix-Ups in NGS

Next-Generation Sequencing (NGS) has become essential in modern genomic diagnostics, yet the complexity of library preparation workflows carries a significant risk of sample mix-ups, estimated at approximately 1% of datasets. These identification errors can have serious clinical consequences, including misdiagnosis. In this live webinar, we will introduce SNPXplex®, an innovative, rapid and cost-effective identitovigilance solution developed by the AP-HP (Assistance Publique – Hôpitaux de Paris). Based on a targeted multiplex PCR assay, SNPXplex® generates a reliable genetic barcode that enables straightforward verification of sample identity against NGS data, thereby enhancing the safety and reliability of genomic analyses.

39th AFH Congress

The 39ᵉ Congrès AFH 2026 will take place in Nîmes, France, from 10–12 June 2026, bringing together histology and histotechnology professionals to explore the latest scientific advances, techniques, and laboratory innovations.

Press Release: Genexpath joins Quimigen Group

Quimigen strengthens its leadership in molecular biology and hemato-oncology with the strategic acquisition of Genexpath, a specialist in in vitro diagnostic solutions for lymphomas and sarcomas.

Press release : Oncomedics joins Quimigen Group

Quimigen Group, a European distributor of reagents and equipment for scientific research and medical diagnosis, has acquired Oncomedics, a French biotechnology company specialising in the personalisation of cancer treatments.